ストックスクリーナーアプリを入手
11.13
3.82%
0.41
アフターアワーズ：
11.13
前日終値:
$10.72
開ける：
$10.81
24時間の取引高:
412.85K
Relative Volume:
0.92
時価総額：
$459.88M
収益：
$313.73M
当期純損益:
$-31.39M
株価収益率:
-14.65
EPS:
-0.7597
ネットキャッシュフロー:
$-3.53M
1週間 パフォーマンス:
+7.64%
1か月 パフォーマンス:
+6.92%
6か月 パフォーマンス:
-8.32%
1年 パフォーマンス:
+19.68%
1日の値動き範囲:
$10.79
$11.24
1週間の範囲:
$10.28
$11.24
52週間の値動き範囲:
$8.36
$13.99
Angiodynamic Inc Stock (ANGO) Company Profile
Compare ANGO vs ISRG, BDX, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
11.13 | 442.94M | 313.73M | -31.39M | -3.53M | -0.7597 |
ISRG
Intuitive Surgical Inc
|
483.62 | 160.28B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.65 | 44.57B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
47.16 | 38.56B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
76.43 | 37.93B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
222.04 | 32.23B | 5.40B | 1.49B | 1.78B | 10.12 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-16 | 開始されました | Lake Street | Buy |
| 2024-04-05 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-09-25 | 開始されました | H.C. Wainwright | Buy |
| 2023-04-17 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | 開始されました | Oppenheimer | Perform |
| 2020-11-25 | アップグレード | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | ダウングレード | Craig Hallum | Buy → Hold |
| 2017-04-07 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2017-03-30 | ダウングレード | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | 開始されました | Barclays | Equal Weight |
| 2016-11-04 | 開始されました | Cantor Fitzgerald | Buy |
| 2016-04-08 | 再開されました | Piper Jaffray | Neutral |
| 2016-01-08 | 繰り返されました | Canaccord Genuity | Buy |
| 2015-11-10 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | 繰り返されました | Canaccord Genuity | Hold |
| 2012-06-25 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | アップグレード | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | ダウングレード | Wedbush | Neutral → Underperform |
| 2010-09-08 | 繰り返されました | Wedbush | Neutral |
すべてを表示
Angiodynamic Inc (ANGO) 最新ニュース
AngioDynamics Growing, But With More Noise Than The Street Likes (NASDAQ:ANGO) - Seeking Alpha
AngioDynamics Inc. Q3 2026 Financial Results: Revenue, Net Loss, and Key Financial Statements Overview - Minichart
AngioDynamics (NASDAQ: ANGO) Q3 2026 revenue up 9% while net loss grows - Stock Titan
AngioDynamics, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
AngioDynamics, Inc. 2026 Q3ResultsEarnings Call Presentation (NASDAQ:ANGO) 2026-04-02 - Seeking Alpha
[8-K] ANGIODYNAMICS INC Reports Material Event - Stock Titan
AngioDynamics Inc (NASDAQ:ANGO) Beats Q3 Earnings Estimates and Raises Full-Year Guidance - ChartMill
AngioDynamics Inc expected to post a loss of 11 cents a shareEarnings Preview - TradingView
AngioDynamics investors can watch Needham conference webcast April 14 - Stock Titan
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 18.0% - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Vanguard disaggregates holdings; reports 0 shares in AngioDynamics (ANGO) - Stock Titan
AngioDynamics schedules April 2 earnings call before market open - Stock Titan
Bard And AngioDynamics Resolve 11-Year Patent Dispute - Law360
AngioDynamics, Inc. $ANGO Shares Acquired by Divisadero Street Capital Management LP - MarketBeat
AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update - MarketBeat
Veeva Systems' Stock Up After Q4 Earnings & Revenues Beat Estimates - Finviz
AngioDynamics, Inc. (NASDAQ:ANGO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 17.6% - MarketBeat
AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 68.70% Potential Upside Amid Healthcare Innovations - DirectorsTalk Interviews
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates - Finviz
Hear AngioDynamics CEO Jim Clemmer live at Leerink healthcare conference - Stock Titan
Can AngioDynamics Inc. stock maintain growth trajectoryWeekly Trade Review & Fast Gain Stock Trading Tips - mfd.ru
Is AngioDynamics Inc. a top pick in the sectorAnalyst Upgrade & Verified Technical Signals - mfd.ru
Bastion Asset Management Inc. Buys 304,960 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
Will AngioDynamics Inc. benefit from rate cutsEarnings Risk Summary & Technical Confirmation Trade Alerts - mfd.ru
DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth - Finviz
Is AngioDynamics Inc. stock influenced by commodity prices2025 Earnings Impact & Proven Capital Preservation Tips - mfd.ru
Essex Investment Management Co. LLC Increases Holdings in AngioDynamics, Inc. $ANGO - MarketBeat
Kevin Kotler discloses 5.9% AngioDynamics (ANGO) stake in 13G filing - Stock Titan
Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect? - Finviz
Here's Why You Should Add Masimo Stock to Your Portfolio Now - Finviz
AngioDynamics summit spotlights tools for clots and tough heart infections - Stock Titan
Here's Why AngioDynamics (ANGO) Is a Great 'Buy the Bottom' Stock Now - Finviz
Reasons to Add AngioDynamics Stock to Your Portfolio for Now - Finviz
Is AngioDynamics Inc. stock a smart retirement pick2025 Trading Recap & Weekly Stock Performance Updates - Mfd.ru
AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring An 81.88% Potential Upside - DirectorsTalk Interviews
Fed Watch: What is XPO Inc.’s market positionWall Street Watch & Smart Allocation Stock Tips - baoquankhu1.vn
Portfolio Update: Will AngioDynamics Inc stock benefit from M AEarnings Overview Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn
RSI Check: Why is AngioDynamics Inc stock going down2025 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - GlobeNewswire Inc.
Treasury Yields: Will AngioDynamics Inc stock recover after earnings2025 Major Catalysts & Proven Capital Preservation Methods - baoquankhu1.vn
AngioDynamics Inc Presents at J.P. Morgan Healthcare Conference - TradingView
AngioDynamics, Inc. (ANGO) Presents at 44th Annual J.P. Morgan Healthcare ConferenceSlideshow - Seeking Alpha
AngioDynamics to lay off 54 workers in Glens Falls, Queensbury - timesunion.com
3 MedTech Stocks Benefiting From Favorable Product Mix Shifts - Finviz
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO) - Finviz
Assessing AngioDynamics (ANGO) Valuation After Raised Guidance And Med Tech Momentum - simplywall.st
How AngioDynamics Inc. stock reacts to oil pricesJuly 2025 PostEarnings & High Conviction Buy Zone Alerts - Улправда
Earnings Beat: Why AngioDynamics Inc. stock is seen as undervaluedWeekly Investment Report & Entry Point Confirmation Alerts - Улправда
Is AngioDynamics Inc. stock a defensive play in 2025Portfolio Risk Report & Low Risk Entry Point Tips - Улправда
Angiodynamic Inc (ANGO) 財務データ
収益
当期純利益
現金流量
EPS
Angiodynamic Inc (ANGO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Trowbridge Stephen A | EVP and CFO |
Oct 13 '25 |
Buy |
11.16 |
890 |
9,932 |
256,629 |
| Clemmer James C | President and CEO |
Oct 09 '25 |
Buy |
11.15 |
10,000 |
111,500 |
882,529 |
0.97%
0.20%
大文字化:
|
ボリューム (24 時間):